Today’s communication by Eawag regarding its study on the pollution of Swiss waters by the chemical and pharmaceutical industry gives rise to misconceptions. Measures already taken as a result of the study are also only mentioned in passing.
Eawag water pollution study: objective impact measurement
Swiss Biotech Report 2022
Swiss foreign trade 2021
Pia Guggenbühl to become Head of Public Affairs and Communications
Pia Guggenbühl will join the Management Board at scienceindustries as Head of Public Affairs and Communications. She will represent the political interests of the Swiss Business Association Chemistry Pharma Life Sciences and will in future also serve as the media contact person.
Chemistry Pharma Life Sciences are a buttress of the economy
Exports for Chemistry Pharma Life Sciences rose to CHF 116.40 billion in 2020 in spite of the COVID-19 crisis. Switzerland's foreign trade benefited significantly from the exports of our industry, which increased to 51.7% last year.
Initiatives jeopardise our competitive ability
At the Annual General Assembly of scienceindustries, Economics Minister Guy Parmelin and representatives of the Chemistry Pharma Life Sciences industry discussed the effects of the termination and responsible business initiatives and concluded that both initiatives should be rejected.
Chemical-pharmaceutical industry plays in the Champions League
When it comes to competitiveness, the chemical-pharmaceutical industry ranks among the world's elite. But this leading position of Switzerland’s biggest export and research industry is jeopardised by the initiative to limit the free movement of persons and the responsible business initiative.
Foreign trade in 2019 for Chemistry Pharma Life Sciences
Exports for Chemistry Pharma Life Sciences improved to a new record high of CHF 114.56 billion in 2019. The share of total Swiss exports rose to 47.3%, whereby this industry now earns nearly one out of every two francs in foreign trade. The US continued to expand its position as the biggest purchaser of Swiss chemical and pharmaceutical products, but the countries in the world’s other regions also made an important contribution to the growth in Swiss exports in 2019.
Foreign trade in 2018 for Chemistry Pharma Life Sciences
Zurich, 1 February 2019
Chemistry Pharma Life Sciences as biggest Swiss export industry continues to grow
Exports for Chemistry Pharma Life Sciences improved to a new record high of CHF 104.33 billion in 2018. At 44.7%, the share of total Swiss exports was on a par with the previous year, so that Chemistry Pharma Life Sciences is still the largest export industry in Switzerland. The US continued to expand its position as the biggest purchaser of chemical and pharmaceutical products from Switzerland, while exports to the UK fell almost by half.
Foreign trade in 2017 for Chemistry Pharma Biotech
Further increase in foreign trade for Switzerland's largest export industry
Exports for Chemistry Pharma Biotech improved to CHF 98.5 billion in 2017. At 44.7%, the share of total Swiss exports was on a par with the previous year, so that Chemistry Pharma Biotech is still the largest export industry in Switzerland. Although pharma exports could not maintain the gains posted in the previous year, they still grew by CHF 3.4 billion to CHF 83.8 billion. At 5.6%, exports by the other Chemistry Pharma Biotech segments increased slightly to CHF 14.7 billion, while their share of the exports of Chemistry Pharma Biotech remains 15%.